Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism

• Published in: Neurobiology of disease Vol. 199; p. 106593
• Main Authors: Adom, M.A., Hahn, W.N., McCaffery, T.D., Moors, T.E., Zhang, X., Svenningsson, P., Selkoe, D.J., Fanning, S., Nuber, S.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-09-2024; Elsevier
• Subjects: Alpha-synuclein; alpha-Synuclein - genetics; alpha-Synuclein - metabolism; Animals; Fatty Acids - metabolism; Female; Hormone-sensitive lipase; Lipe; Lipid Metabolism - physiology; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Parkinson Disease - genetics; Parkinson Disease - metabolism; Parkinson's disease; Sex Characteristics; Sterol Esterase - genetics; Sterol Esterase - metabolism; Hormone-sensitive lipase; Parkinson's disease; Lipe; Alpha-synuclein
• ISSN: 0969-9961; 1095-953X; 1095-953X
• DOI: 10.1016/j.nbd.2024.106593

Impaired lipid metabolism is a risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB) and can shift the physiological α-synuclein (αS) tetramer-monomer (T:M) ratio toward aggregation prone monomers. A resultant increase in phospho-serine 129+ αS monomers associating with excess mono- and polyunsaturated fatty acids contributes to the αS aggregation. We previously reported that decreasing the release of monounsaturated fatty acids (MUFAs) by reducing or inhibiting the hormone sensitive lipase (LIPE) reversed pathologic αS phosphorylation and improved soluble αS homeostasis in cultured αS triplication PD neurons and reduced DAergic neurodegeneration in a C.elegans αS model. However, assessing LIPE as a potential therapeutic target for progressive PD motor phenotypes has not been investigated. 3K αS mice, representing a biochemical and neuropathological amplification of the E46K fPD-causing mutation, have decreased αS T:M ratios, lipidic aggregates, and a L-DOPA responsive PD-like motor syndrome. Here, we reduced LIPE by crossings of 3K mice with LIPE null mice, which attenuated motor deficits in male LIPE+/− knockdown (LKD)-3K mice. Heterozygous LIPE reduction was associated with an improved αS T:M ratio, and dopaminergic neurotransmitter levels and fiber densities. In female 3K-LKD mice, an increase in pS129+ and larger lipid droplets (LDs) likely decreased the benefits seen in males. Reducing LIPE decreased MUFA release from neutral lipid storage, thereby reducing MUFA in phospholipid membranes with which αS interacts. Our study highlights fatty acid turnover as a therapeutic target for Lewy body diseases and support LIPE as a promising target in males. LIPE regulation represents a novel approach to mitigate PD and DLB risk and treat disease.
•LIPE knockdown lessens a robust and rapid PD-like syndrome of male 3K αS mutant mice•Increased αS tetramer:monomer ratios benefit neutral lipid metabolism and the PD-like syndrome•Therapeutic LIPE knockdown supports an intersection between αS and lipid homeostasis in PD